For Research Use Only
KLOW is a multi-component research formulation combining four distinct peptides:
GHK-Cu — a copper-binding tripeptide investigated for fibroblast activity, collagen synthesis and extracellular-matrix remodeling.
BPC-157 — a synthetic 15-amino-acid peptide studied primarily in preclinical models involving connective tissue, cellular migration, vascular signaling and gastrointestinal biology.
TB-500 — a Thymosin Beta-4-related research peptide investigated in connection with actin dynamics, cellular migration and tissue-remodeling pathways.
KPV (Lys-Pro-Val) — a tripeptide derived from the C-terminal region of α-MSH and investigated particularly for inflammatory-signaling pathways.
KLOW is therefore not one peptide or one new molecule. It is a mixture of four chemically distinct research compounds.
KLOW’s individual components have been investigated in research involving:
Importantly, these research areas come from studies of the individual components or related molecules, rather than controlled studies establishing the effects of the KLOW combination itself.
GHK-Cu → Copper-Peptide Signaling → Fibroblast & Extracellular-Matrix Biology
Research interests include collagen, elastin, fibroblast activity, dermal biology and tissue remodeling.
BPC-157 → Cellular Migration / Vascular-Associated Signaling → Tissue-Repair Models
Experimental research has explored tendon biology, fibroblast migration, endothelial signaling and gastrointestinal tissue responses.
Tβ4-Related Biology → Actin Regulation → Cellular Migration → Tissue Remodeling
This component is associated with research into actin dynamics, cell migration, angiogenesis and wound-healing biology.
KPV → Cellular Signaling → NF-κB-Associated Pathways
KPV has been investigated particularly in experimental inflammatory and intestinal models, including work involving inflammatory cytokine signaling.
This is a useful distinction for your customers.
GLOW:
GHK-Cu + BPC-157 + TB-500
KLOW:
GHK-Cu + BPC-157 + TB-500 + KPV
So KLOW essentially expands the GLOW research concept by adding KPV and its inflammatory-signaling research pathway. However, no controlled head-to-head study has established that adding KPV makes KLOW superior to GLOW.
The rationale for studying the combination is the ability to investigate several complementary biological systems:
GHK-Cu
Extracellular matrix • Collagen • Fibroblasts
BPC-157
Cell migration • Vascular signaling • Connective-tissue models
TB-500
Actin dynamics • Cytoskeleton • Cellular migration
KPV
Inflammatory signaling • NF-κB-associated pathways
Together, these create a research framework involving:
Inflammatory Signaling ↔ Cellular Migration ↔ Vascular Biology ↔ Extracellular-Matrix Remodeling
That is a mechanistic research rationale—not evidence that the combination produces synergistic effects in humans.
✔ Premium Research-Grade Blend
✔ GHK-Cu + BPC-157 + TB-500 + KPV
✔ Four-Component Research Formulation
✔ Third-Party Tested (COA Available)
✔ Identity & Purity Verification
✔ Batch & Lot Traceability
✔ Secure Professional Packaging
✔ Laboratory Research Only
Researchers may investigate KLOW in laboratory models involving connective-tissue physiology, extracellular-matrix remodeling, fibroblast biology, cellular migration, inflammatory signaling, endothelial physiology, collagen biology, cytoskeletal dynamics and regenerative-biology pathways.
Store according to the product’s batch-specific stability documentation.
Protect lyophilized material from excessive heat, moisture and direct sunlight. Following preparation for laboratory experiments, use validated laboratory storage procedures and minimize unnecessary temperature cycling or repeated freeze-thaw exposure.
KLOW is a commercial/research blend name rather than a standardized pharmaceutical formulation.
Different suppliers may use different amounts of its four components, and published findings for GHK-Cu, BPC-157, KPV or Thymosin Beta-4-related research cannot automatically be attributed to the combined KLOW formulation. Available research-oriented sources likewise note the lack of controlled studies on the complete four-component mixture.
For Voltis, the exact GHK-Cu / BPC-157 / TB-500 / KPV amounts should therefore match your batch-specific COA and vial label.
For Research Use Only.
KLOW is an investigational multi-component research formulation. Research involving its individual components should not be interpreted as establishing the safety or effectiveness of the combined formulation for treating injuries, inflammation, gastrointestinal conditions, skin conditions or other diseases.
This Voltis Research Co. product is intended exclusively for laboratory research and analytical purposes.
Not intended for human or veterinary use.
At Voltis Research Co., quality begins with verification. This is particularly important with multi-component formulations, where researchers need confidence that the identity and composition of each constituent correspond to the product specification.
Qualifying batches undergo independent third-party analytical testing, with batch-specific Certificates of Analysis available to document identity and purity.
⚡ Research-Grade Quality
⚡ Independent Third-Party Testing
⚡ Batch-Specific Certificate of Analysis (COA)
⚡ High-Purity Research Peptides
⚡ Multi-Component Identity Verification
⚡ Rigorous Quality Control
⚡ Secure Professional Packaging
⚡ Transparency, Consistency & Reliability
Powering Discovery Through Quality Research.
$120.00
Related Products
Voltis supplies peptides and research compounds intended for laboratory and research purposes only.
These products are not approved for human consumption and have not been evaluated by the FDA.
By entering this website, you acknowledge that you are at least 21 years of age and understand the intended use of these products.
Added to cart
Check out our shop to see what's available